Retinoblastoma

Jump to navigation Jump to search

For patient information click here

Template:DiseaseDisorder infobox

Retinoblastoma Microchapters

Home

Patient Information

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Retinoblastoma from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Retinoblastoma On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Retinoblastoma

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Retinoblastoma

CDC on Retinoblastoma

Retinoblastoma in the news

Blogs on Retinoblastoma

Directions to Hospitals Treating Retinoblastoma

Risk calculators and risk factors for Retinoblastoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Treatment

Until recently the only treatment was to remove the affected eyeball before the cancer spread. Chemotherapy is the treatment of choice for most unilateral cases. However with locally advanced disease external beam radiation may be needed and if both eyes are involved enucleation may be the only option. Affected children in developing countries present with advanced features and usually die of metastatic spread. In its initial stages, retinoblastoma is very similar to Coats disease, a non-cancerous retina disease. Coats' Disease should be ruled out before enucleation is done. A mis-diagnosis of Retinoblastoma accounts for the greatest number of Coats' disease eyes being enucleated.

Many children with bilateral retinoblastoma can be treated with a preservation attempt. Tumor chemoreduction with carboplatin and other drugs may reduce the tumor volume making them amenable to local therapies [1]

Local therapies include-

Laser therapy (Uses infrared laser light to precisely destroy the blood vessels surrounding a tumor.)

  • Cryotherapy (use of a cold gas which is injected into the affected part of the retina to shrink the tumor.)
  • Thermotherapy (A relatively new technique used mainly in new testing. It uses the principle that if heat is applied to the affected area, a tumor will sustain more damage than healthy cells because healthy cells can cool themselves better using healthy surrounding blood vessels. If this technique is not immediately successful it may increase the efficacy of other treatments such as chemotherapy and focused radiation plaques.)
  • Radiotherapy (Generally used as a last resort, radiotherapy was previously the treatment of choice before the above mentioned treatments were developed. Radiotherapy destroys cancerous growths using gamma radiation but it carries with it many drawbacks, including:-
    • Possibility of secondary cancerous growths which present themselves months or years later.
    • Destruction of healthy cells in the area surrounding the treated tumor.
    • Bone deformation due to the destruction of the growth plates mainly in the area of the temple.)

It is important that children with retinoblastoma are treated in specialist centers.

Brachytherapy with beta-emitting eye applicators have also been a successful major treatment. BEBIG (GmbH-Berlin-Germany) produces various kinds of ruthenium ophthalmic applicators for treating retinoblastoma.

See Ben Underwood for a case who compensated for the resulting blindness by developing human echolocation.

In October 2007, researchers have identified the specific cell that causes retinoblastoma.[2]

References

  1. Dunkel IJ, Lee TC, Shi W, Beaverson KL, Novetsky D, Lyden D, Finlay JL, McCormick B, Abramson DH. "A phase II trial of carboplatin for intraocular retinoblastoma". Pediatr Blood Cancer. PMID 17301956.

See also

External links


Template:Nervous tissue tumors


de:Retinoblastom nl:Retinoblastoom fi:Retinoblastooma ur:شبکی ورمِ ارومہ


Template:WikiDoc Sources